Show simple item record

Authordc.contributor.authorDhatariya, Ketan K. 
Authordc.contributor.authorGlaser, Nicole S. 
Authordc.contributor.authorCodner Dujovne, Ethel 
Authordc.contributor.authorUmpierrez, Guillermo E. 
Admission datedc.date.accessioned2021-07-30T21:04:43Z
Available datedc.date.available2021-07-30T21:04:43Z
Publication datedc.date.issued2020
Cita de ítemdc.identifier.citationNature Reviews Disease Primers Volume 6 Issue1 (2020)es_ES
Identifierdc.identifier.other10.1038/s41572-020-0165-1
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/180804
Abstractdc.description.abstractDiabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology, pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children.es_ES
Patrocinadordc.description.sponsorshipmerican Diabetes Association 1-17-IBS-186 United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) U34DK123894 Fondo Nacional de Ciencia y Tecnologia (FONDECYT) from the Government of Chile 1170895 National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) from the Clinical and Translational Science Award program UL1TR002378 United States Department of Health & Human Services National Institutes of Health (NIH) - USA U30 P30DK11102 Dexcom Novo Nordisk Sanofies_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherNaturees_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceNature Reviews Disease Primerses_ES
Keywordsdc.subjectHyperosmolar hyperglycemic statees_ES
Keywordsdc.subjectSubcutaneous insulin infusiones_ES
Keywordsdc.subjectIntravenous regular insulines_ES
Keywordsdc.subjectMultiple organ failurees_ES
Keywordsdc.subjectAmino-acid levelses_ES
Keywordsdc.subjectLow-dose insulinquality-of-lifees_ES
Keywordsdc.subjectCerebral edemaes_ES
Keywordsdc.subjectSevere hypoglycemiaes_ES
Keywordsdc.subjectOxidative stresses_ES
Títulodc.titleDiabetic ketoacidosises_ES
Document typedc.typeArtículo de revistaes_ES
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogueruchile.catalogadorcrbes_ES
Indexationuchile.indexArtículo de publicación ISI
Indexationuchile.indexArtículo de publicación SCOPUS


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile